The Centers for Disease Control and Prevention (CDC) recently released its annual report on X-ray therapy for heart disease and cancer, a list that included xerotectomies.
According to the CDC, the treatment has proven successful in treating a number of other medical conditions, including the treatment of leukemia and Hodgkin’s lymphoma.
However, in some cases, patients have died after using the therapy, such as in the case of a 33-year-old man in Minnesota who died in 2011 after a year of treatment.
A group of researchers recently published a study that looked at the results of 12 patients treated with xerodinedomies who had died.
They found that, among the 12 patients, seven had been treated with at least one other treatment, with a total of seven treatment-related deaths.
Of those seven, two had died within the past 12 months, and two more had died more than a year after the treatment, the researchers wrote.
The researchers said that these deaths were not due to the use of other medications, but rather to the lack of care and coordination among doctors, nurses and other medical personnel.
The CDC said that while most patients who died from X-rays had no known underlying medical conditions other than cancer, it is possible that they may have received other treatments such as chemotherapy, radiation therapy, or medications to treat heart disease or cancer.
They recommended that doctors monitor patients for signs of possible side effects before the use and treatment of treatments that could be related to heart disease.
If your health care provider prescribes xerotropies or other therapies for a heart disease diagnosis, discuss it with them to make sure they are safe, according to the study.